At Least 7 Families Say Zofran Causes Birth Defects. But What Else Have They Claimed?
Multiple families have now filed legal claims against GlaxoSmithKline, in an ongoing litigation that involves the company’s anti-nausea drug Zofran. These parents allege that Zofran, which... Read More
Zofran Has Now Been Linked To Major Birth Defects. Have GlaxoSmithKline & The FDA Responded?
Since its approval in 1991, the anti-nausea drug Zofran has undergone several major labeling revisions. For a pharmaceutical product, this isn’t uncommon. When a drug... Read More
Pay To Promote: The Pharmaceutical Industry’s Financial Relationships With Doctors
In our last article, we discussed a series of charges filed by the US Department of Justice against the international pharmaceutical giant GlaxoSmithKline. We focused... Read More
Paying Doctors To Promote Drugs “Off Label”: The US Government’s Case Against GlaxoSmithKline
In 2012, the US Department of Justice brought a series of charges, both civil and criminal, against the London-based pharmaceutical conglomerate GlaxoSmithKline. Those charges were... Read More
9 Birth Defects Named In Zofran Lawsuits
Ondansetron, a powerful anti-nausea drug, is manufactured by GlaxoSmithKline under the brand name Zofran. Since at least the mid-1990s, Zofran has been America’s top-selling drug... Read More
